VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ONC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ONCBeOne Medicines Ltd.
$289.99$31.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksONCQuarterly Cash Flow

BeOne Medicines Ltd. (ONC) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

BeOne Medicines Ltd. (ONC) quarterly cash flow statement — complete operating, investing & financing history

ONC Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Cash from Operations201.94M417.35M402.55M263.6M44.08M75.16M188.37M-95.59M-308.57M-221.64M-78.15M-293.89M-563.78M-318.19M-561.91M-379.96M-236.56M-507.84M-495.71M-420.27M
Operating CF Margin %13.34%27.86%28.5%20.04%3.95%6.66%18.81%-10.29%-41.05%-34.94%-10%-49.37%-125.9%-83.71%-144.96%-111.24%-77.15%-237.33%-240.12%-280.19%
Operating CF Growth %358.09%455.28%113.7%375.76%114.29%133.91%341.04%67.47%45.27%30.34%86.09%22.65%-138.32%37.34%-13.35%9.59%-289.11%-52.81%-43.17%-59.83%
Net Income228.03M382.52M124.84M94.32M1.27M-151.88M-121.35M-120.41M-251.15M-367.55M215.41M-381.14M-348.43M-445.33M-552.76M-571.45M-434.27M-585.65M-413.86M-480.34M
Depreciation & Amortization41.27M210.1M37.28M35.61M32.8M50.25M71.29M24.93M25.29M23.82M21.51M22.34M20.01M18.02M16.2M15.46M16.6M13.12M12.18M11.53M
Stock-Based Compensation0757.14M140.79M150.81M95.48M107.62M114.7M130.64M88.71M92.92M96M103.37M75.32M78.13M78.18M81.31M65.56M63.01M67.08M64.79M
Deferred Taxes09.47M0000000-46K750K-51K36K1.68M-7.17M12.84M-5.29M-2.68M-26.1M-60K
Other Non-Cash Items122.34M-1.11B28.09M-22.5M-7.44M88.04M-6.74M-17.34M-16.07M12.2M-353.67M-3.07M-16.65M29.52M-10.52M-14.39M-1.3M15.69M-45.64M26.68M
Working Capital Changes-189.71M164M71.55M5.35M-78.03M-18.86M130.47M-113.41M-155.36M17.02M-58.16M-35.34M-294.06M-197K-85.84M96.28M122.14M-11.33M-89.38M-42.87M
Change in Receivables-75.52M2.23M-93.92M-41.5M-31.87M-125.7M-29.85M-93.87M-80.03M-44.8M-11.59M4.56M-136.49M19.39M-22.71M14.88M292.55M-353.85M-55.84M10.32M
Change in Inventory-72.05M-70.71M-28.84M2.19M3.99M-79.38M23.84M1.31M-37.26M-88.58M1.23M-40.57M-13.03M18.94M-44M-28.63M-3M-91.65M-33.39M-44.61M
Change in Payables-42.31M87.44M0-4.28M-31.57M107.96M11.34M-44.11M46.3M-9.88M64.04M-10.09M-22.59M-8.55M34.56M4.66M-35.02M32.38M30.18M30.62M
Cash from Investing-45.65M-38.6M-49.27M-66.61M-121.94M-93.61M-133.88M-111.03M-209.83M-62.58M-186.28M67.8M241.06M38.54M169.48M658.71M210.39M109.11M-11.99M251.6M
Capital Expenditures-40.91M-286.07M-48.08M-43.83M-56.41M-92.48M-133.66M-109.95M-193.05M-156.96M-157.88M-121.47M-125.58M-170.02M-128.66M-50.29M-120.13M-158.39M-67.04M-38.53M
CapEx % of Revenue2.7%19.09%3.4%3.33%5.05%8.2%13.34%11.83%25.68%24.74%20.21%20.41%28.04%44.73%33.19%14.72%39.18%74.02%32.48%25.69%
Acquisitions0000000000000-159.89M-278.14M-709M0-43.41M00
Investments--------------------
Other Investing-4.76M254.06M-1.19M-22.78M-67.33M-1.13M-227K-1.08M-19.43M-9.95M-24.41M9.25M-9.25M159.89M278.14M709M050.91M0-7.5M
Cash from Financing68.84M97.83M961.27M35.02M-33.78M-4.52M12.66M23.02M162.29M347.05M-76.78M166.08M-19.87M-110.37M120.24M-17.58M-11.27M3.38B109.21M35.63M
Debt Issued (Net)48.15M78.43M-4.26M26.08M-97.14M-13.32M-3.56M14.45M147.5M343.69M-93.97M162.5M-51.46M-121.65M103.54M-24.67M-23.15M-18.53M12.62M25.78M
Equity Issued (Net)23.95M19.41M0000000000000003.39B50M0
Dividends Paid00000000000000000000
Share Repurchases00000000000000000000
Other Financing-3.26M-16.18K965.53M8.95M63.36M8.79M16.22M8.56M14.79M3.36M17.18M3.58M31.59M11.29M16.7M7.09M11.88M10.57M46.59M9.85M
Net Change in Cash243.83M499.11M1.32B255.5M-108.16M-74.68M95.5M-189.5M-378.55M105.09M-340.68M-122.19M-331.27M-325.48M-334.9M180.96M-28.44M2.99B-396.99M-123.72M
Free Cash Flow161.03M131.28M354.47M199.77M-72.33M-17.32M54.71M-205.54M-501.62M-388.55M-260.44M-415.36M-689.36M-488.21M-690.56M-430.25M-356.69M-666.23M-562.76M-458.8M
FCF Margin %10.64%8.76%25.1%15.19%-6.47%-1.54%5.46%-22.12%-66.74%-61.25%-33.33%-69.78%-153.94%-128.45%-178.15%-125.96%-116.33%-311.35%-272.6%-305.88%
FCF Growth %322.64%857.94%547.86%197.19%85.58%95.54%121.01%50.52%27.23%20.41%62.29%3.46%-93.26%26.72%-22.71%6.22%-580.68%-71.25%-33.54%-55.24%
FCF per Share1.391.163.101.77-0.65-0.160.52-1.96-4.81-3.73-2.44-3.97-6.62-4.71-6.67-4.19-3.48-7.01-6.07-4.99
FCF Conversion (FCF/Net Income)0.89x6.28x3.22x2.79x34.71x-0.49x-1.55x0.79x1.23x0.60x-0.36x0.77x1.62x0.71x1.01x0.67x0.54x0.87x1.13x0.87x
Interest Paid0012.13M11.81M12.21M13.01M14.01M12.71M11.44M3.86M5.88M5M5.02M5.3M6.97M6.28M6.62M6.57M9.13M7.34M
Taxes Paid00067.71M9.32M14.65M9.14M43.15M2.49M13.49M9.99M24.91M7.62M4.49M570K23.7M736K481K687K14.05M